Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 646-653

  Martens, Fabrice M A C ^a   van der Graaf, Yolanda ^a   Dijk, Joke M ^a   Olijhoek, Jobien K ^a   Visseren, Frank L J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carotid artery stiffness; Diabetes mellitus; Metabolic syndrome

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; CAROTID ARTERY; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY ARTERY STENOSIS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL;

AGED; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MALE; MANOMETRY; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 40949123771     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.02.019     Document Type: Article

References (44)

1. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
2. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
3. Watson K.E., Peters Harmel A.L., and Matson G. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance. J Cardiovasc Pharmacol Ther 8 (2003) 253-260
4. Levantesi G., Macchia A., Marfisi R., et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 46 (2005) 277-283
5. Olijhoek J.K., van der G.Y., Banga J.D., et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 25 (2004) 342-348
6. Schillaci G., Pirro M., Vaudo G., et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45 (2005) 1078-1082
7. de Vegt F., Dekker J.M., Jager A., et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285 (2001) 2109-2113
8. Resnick H.E., Jones K., Ruotolo G., et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26 (2003) 861-867
9. Laaksonen D.E., Lakka H.M., Niskanen L.K., et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156 (2002) 1070-1077
10. Dijk J.M., Algra A., van der G.Y., Grobbee D.E., and Bots M.L. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J 26 (2005) 1213-1220
11. Cohn J.N. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 113 (2006) 601-603
12. O'Leary D.H., and Polak J.F. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90 (2002) 18L-21L
13. Liao D., Arnett D.K., Tyroler H.A., et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 34 (1999) 201-206
14. Arnett D.K., Evans G.W., and Riley W.A. Arterial stiffness: a new cardiovascular risk factor?. Am J Epidemiol 140 (1994) 669-682
15. Gatzka C.D., Cameron J.D., Kingwell B.A., and Dart A.M. Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 32 (1998) 575-578
16. Dijk J.M., van der G.Y., Grobbee D.E., Banga J.D., and Bots M.L. Increased arterial stiffness is independently related to cerebrovascular disease and aneurysms of the abdominal aorta: the Second Manifestations of Arterial Disease (SMART) Study. Stroke 35 (2004) 1642-1646
17. Dijk J.M., van der G.Y., Grobbee D.E., and Bots M.L. Carotid stiffness indicates risk of ischemic stroke and TIA in patients with internal carotid artery stenosis: the SMART study. Stroke 35 (2004) 2258-2262
18. Tsivgoulis G., Vemmos K., Papamichael C., et al. Common carotid arterial stiffness and the risk of ischaemic stroke. Eur J Neurol 13 (2006) 475-481
19. Avolio A.P., Deng F.Q., Li W.Q., et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 71 (1985) 202-210
20. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194
21. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
22. Henry R.M., Kostense P.J., Spijkerman A.M., et al. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn study. Circulation 107 (2003) 2089-2095
23. Salomaa V., Riley W., Kark J.D., Nardo C., and Folsom A.R. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 91 (1995) 1432-1443
24. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
25. Urbina E.M., Srinivasan S.R., Kieltyka R.L., et al. Correlates of carotid artery stiffness in young adults: the Bogalusa Heart study. Atherosclerosis 176 (2004) 157-164
26. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., and van der G.Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 15 (1999) 773-781
27. Simons P.C., Algra A., Bots M.L., Grobbee D.E., and van der G.Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation 100 (1999) 951-957
28. Stork S., van den Beld A.W., von Schacky C., et al. Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study. Circulation 110 (2004) 344-348
29. O'Rourke M.F., Staessen J.A., Vlachopoulos C., Duprez D., and Plante G.E. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 15 (2002) 426-444
30. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
31. Meigs J.B. Epidemiology of the metabolic syndrome, 2002. Am J Manage Care 8 (2002) S283-S292
32. Rantala A.O., Kauma H., Lilja M., et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 245 (1999) 163-174
33. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
34. Caballero A.E. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch Med Res 36 (2005) 241-249
35. Baron A.D. Vascular reactivity. Am J Cardiol 84 (1999) 25J-27J
36. Steinberg H.O., and Baron A.D. Vascular function, insulin resistance and fatty acids. Diabetologia 45 (2002) 623-634
37. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20 (2003) 255-268
38. McVeigh G.E., Brennan G.M., Johnston G.D., et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 771-776
39. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., and Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 263 (1990) 2893-2898
40. Standl E., and Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 43 (2000) 1455-1469
41. Fichtlscherer S., Rosenberger G., Walter D.H., et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102 (2000) 1000-1006
42. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
43. Chia S., Qadan M., Newton R., et al. Intra-arterial tumor necrosis factor-{alpha} impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol 23 (2003) 695-701
44. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428